Single center experience on dosing and adverse events of recombinant factor seven use for bleeding after congenital heart surgery

There are limited data on the relationship between the administered dose of recombinant factor seven (rFVIIa) and the development of adverse clinical outcomes after congenital heart surgery. This single institution case series reports on dosing, adverse events, and blood product usage after the admi...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Journal of the Saudi Heart Association. - 1999. - 27(2015), 1 vom: 17. Jan., Seite 18-22
1. Verfasser: Kurkluoglu, Mustafa (VerfasserIn)
Weitere Verfasser: Engle, Alyson M, Costello, John P, Hibino, Narutoshi, Zurakowski, David, Jonas, Richard A, Berger, John T, Nath, Dilip S
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2015
Zugriff auf das übergeordnete Werk:Journal of the Saudi Heart Association
Schlagworte:Journal Article Bleeding Cardiac surgery Congenital heart disease ECMO Recombinant factor VIIa